APOE and dementia: On average, the PRS was associated with approximately 25% (95%CI 21%∼28%) higher risk of incident dementia, and the participants with high-risk group (APOE ε4 dosage = 2) had greater risk of incident dementia, with a HR of 8.64 (95%CI 7.73∼9.67).